Search results for "Assay"

showing 10 items of 2241 documents

A monoclonal Ro-antibody and the serum of a Ro-positive patient with subacute cutaneous lupus erythematosus (SCLE) react with basal layers of human e…

1988

Skin lesions, especially at areas exposed to sunlight, prove to be a major form of manifestation of diseases related to Ro-antibodies and neonatal-, 'ANA-negative-', and cutaneous types of lupus erythe- matosus. A monoclonal Ro-antibody established by our group reacts with a 60 kD polypeptide in extracts from human spleen, whereas in extracts from human epidermis the monoclonal Ro-antibody and a purified Ro-antibody from a monospecific serum of a patient with subacute cutaneous lupus erythematosus reacted with a 60 kD and a 48 kD protein. Performing immunofluorescence microscopy on HEp2-cells both antibodies showed a nuclear speckled staining pattern and a reaction with cytokeratin filament…

Pathologymedicine.medical_specialtymedicine.drug_classClinical BiochemistryBlotting WesternFluorescent Antibody TechniqueEnzyme-Linked Immunosorbent AssayMonoclonal antibodyImmunofluorescenceBiochemistrySubacute cutaneous lupus erythematosusmedicineLupus Erythematosus CutaneousHumansskin and connective tissue diseasesSystemic lupus erythematosusbiologyEpidermis (botany)medicine.diagnostic_testAntibodies MonoclonalGeneral Medicinemedicine.diseaseAntibodies AntinuclearMonoclonalbiology.proteinAntibodyEpidermisAnti-SSA/Ro autoantibodiesEuropean journal of clinical investigation
researchProduct

Acute Morphological and Toxicological Effects in a Human Bronchial Coculture Model after Sulfur Mustard Exposure

2009

International audience; Sulfur mustard (SM) is a strong alkylating agent. Inhalation of SM causes acute lung injury accompanied by severe disruption of the airway barrier. In our study, we tested the acute effects after mustard exposure in an in vitro coculture bronchial model of the proximal barrier. To achieve this, we seeded normal human bronchial epithelial explant-outgrowth cells (HBEC) together with lung fibroblasts as a bilayer on filter plates and exposed the bronchial model after 31 days of differentiation to various concentrations of SM (30, 100, 300, and 500mM). The HBEC formed confluent layers, expressing functional tight junctions as measured by transepithelial electrical resis…

Pathologymedicine.medical_specialtysulfur mustard[SDV]Life Sciences [q-bio]ApoptosisBronchiEnzyme-Linked Immunosorbent Assay[SDV.BC]Life Sciences [q-bio]/Cellular BiologyBiologyLung injuryToxicologyCell LinelungProinflammatory cytokinechemistry.chemical_compoundIn vivoMustard GasmedicineHumansChemical Warfare AgentsInterleukin 8Tight junctionInterleukinSulfur mustardprimary bronchial cellsMolecular biologyCoculture TechniqueschemistryApoptosis[SDV.TOX]Life Sciences [q-bio]/ToxicologyMicroscopy Electron ScanningbarriercocultureToxicological Sciences
researchProduct

Tyramine and phenylethylamine production among lactic acid bacteria isolated from wine.

2007

The ability of wine lactic acid bacteria to produce tyramine and phenylethylamine was investigated by biochemical and genetic methods. An easy and accurate plate medium was developed to detect tyramine-producer strains, and a specific PCR assay that detects the presence of tdc gene was employed. All strains possessing the tdc gene were shown to produce tyramine and phenylethylamine. Wines containing high quantities of tyramine and phenylethylamine were found to contain Lactobacillus brevis or Lactobacillus hilgardii. The main tyramine producer was L. brevis. The ability to produce tyramine was absent or infrequent in the rest of the analysed wine species.

Pcr assayved/biology.organism_classification_rank.speciesColony Count MicrobialTyramineWineLactobacillus hilgardiiMicrobiologychemistry.chemical_compoundPhenethylaminesFood microbiologyWinebiologyLactobacillus brevisved/biologyfood and beveragesGeneral MedicineTyramineTyrosine Decarboxylasebiology.organism_classificationLactic acidCulture MediaLactobacilluschemistryBiochemistryFood MicrobiologyBacteriaFood ScienceInternational journal of food microbiology
researchProduct

Comparative histological, histochemical, immunohistochemical and biochemical studies on oestrogen receptors, lectin receptors, and Barr bodies in hum…

1986

The present study performed on a total of 567 cases of human female breast cancer compares the results of the biochemical assay (dextran-coated charcoal assay = DCC) for oestrogen receptor (ER) with those of several morphological methods developed for the detection of the ER or for the prediction of prognosis by use of other systems (FSA = fluorescent ligand binding assay, ER-ICA = monoclonal antibody assay for ER, LRA = lectin receptor assay using peanut agglutinin, and Barr body estimation). Whereas no correlation at all was observed among the results of the DCC and those of the FSA and Barr body estimation, the ER-ICA and the LRA showed an unanimous tendency towards higher values of ER w…

Peanut agglutininPathologymedicine.medical_specialtymedicine.drug_classBreast NeoplasmsMonoclonal antibodyPathology and Forensic MedicinePeanut AgglutininLectinsmedicineHumansLymphocytesReceptorMolecular BiologyFluorescent DyesImmunoassaybiologyHistocytochemistryLigand binding assayAssayCancerAntibodies MonoclonalDextransCell BiologyGeneral Medicinemedicine.diseaseFluoresceinsMolecular biologyReceptors EstrogenSex ChromatinCharcoalReceptors MitogenMonoclonalbiology.proteinImmunohistochemistryFemaleFluorescein-5-isothiocyanateThiocyanatesVirchows Archiv. A, Pathological anatomy and histopathology
researchProduct

Evaluation of a rapid antigen detection test (Panbio™ COVID‐19 Ag Rapid Test Device) as a point‐of‐care diagnostic tool for COVID‐19 in a pediatric e…

2021

Abstract We evaluated the Panbio™ COVID‐19 Ag Rapid Test Device as a point‐of‐care diagnostic tool for COVID‐19 in 357 patients at a pediatric emergency department. Thirty‐four patients tested positive by reverse transcription polymerase chain reaction, of which 24 were positive by the antigen assay. The sensitivity and specificity of the assay were 70.5% and 100%, respectively.

Pediatric emergencyMale2019-20 coronavirus outbreakmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)emergency departmentShort CommunicationShort CommunicationsSARS‐CoV‐2 RNA viral loadfield evaluationImmunologic TestsSensitivity and SpecificityCOVID-19 Serological TestingAntigenVirologyInternal medicineNasopharynxmedicineHumansProspective StudiesChildAntigens ViralPoint of carepediatric patientsbusiness.industrySARS-CoV-2clinical sensitivityCOVID-19InfantEmergency departmentVirologyTest (assessment)Reverse transcription polymerase chain reactionInfectious Diseasesrapid antigen assayPoint-of-Care TestingCOVID-19 Nucleic Acid TestingChild PreschoolFemalebusinessEmergency Service HospitalJournal of Medical Virology
researchProduct

Disease expression in women with hereditary angioedema

2008

Udgivelsesdato: 2008-Jun-11 OBJECTIVE: Fluctuations in sex hormones can trigger angioedema attacks in women with hereditary angioedema. Combined oral contraceptive therapies, as well as pregnancy, can induce severe attacks. The course of angioedema may be very variable in different women. STUDY DESIGN: Within the PREHAEAT project launched by the European Union, data on 150 postpubertal women with hereditary angioedema were collected in 8 countries, using a patient-based questionnaire. RESULTS: Puberty worsened the disease for 62%. Combined oral contraceptives worsened the disease for 79%, whereas progestogen-only pills improved it for 64%. During pregnancies, 38% of women had more attacks, …

PediatricsDiseaseMESH: HormonesMESH: Pregnancy0302 clinical medicinePregnancyMESH: ProgesteroneMESH: ChildImmunopathologyMESH: Contraceptives Oral CombinedMESH: Puberty030212 general & internal medicineskin and connective tissue diseasesProgesteronemedia_commonMESH: Middle AgedMESH: Complement Hemolytic Activity AssayMESH: Angioedema HereditaryVaginal deliveryfood and beveragesObstetrics and GynecologyMESH: Complement C4[SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismMiddle AgedMenstruation3. Good healthContraceptives Oral CombinedMESH: Pregnancy ComplicationsPillHereditary angioedemaFemalemedicine.symptomAdultmedicine.medical_specialtyMESH: PedigreeMESH: Complement C1 Inactivator ProteinsMESH: Menstruation[SDV.MHEP.GEO]Life Sciences [q-bio]/Human health and pathology/Gynecology and obstetrics03 medical and health sciencesmedicineMESH: AngioedemaHumansmedia_common.cataloged_instanceEuropean unionPregnancyMESH: HumansAngioedemabusiness.industryPubertyAngioedemas HereditaryMESH: AdultDelivery Obstetricmedicine.diseaseHormonesMESH: RecurrenceSurgeryMESH: Abdominal PainPregnancy Complications030228 respiratory systemMESH: Delivery ObstetricbusinessMESH: FemaleAmerican Journal of Obstetrics and Gynecology
researchProduct

Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy, February 2020

2020

A novel coronavirus (SARS-CoV-2) has been identified as the causative pathogen of an ongoing outbreak of respiratory disease, now named COVID-19. Most cases and sustained transmission occurred in China, but travel-associated cases have been reported in other countries, including Europe and Italy. Since the symptoms are similar to other respiratory infections, differential diagnosis in travellers arriving from countries with wide-spread COVID-19 must include other more common infections such as influenza and other respiratory tract diseases.

Pediatricsmedicine.medical_specialtyEpidemiologyPneumonia Viralrespiratory pathogensdifferential diagnosiSettore MED/42 - Igiene Generale E Applicatamedicine.disease_causeDisease OutbreaksDiagnosis DifferentialBetacoronavirusCOVID-19 TestingVirologydifferential diagnosisInfluenza HumanMedicineHumansMass Screeningrapid molecular assayRespiratory Tract InfectionsMass screeningCoronavirusTravelbiologyCOVID-19 ; respiratory pathogens ; differential diagnosis ; SARS-CoV-2 ; rapid molecular assaybusiness.industryTransmission (medicine)SARS-CoV-2Clinical Laboratory TechniquesRespiratory diseasePublic Health Environmental and Occupational HealthOutbreakCOVID-19medicine.diseasebiology.organism_classificationPneumoniamedicine.anatomical_structureItalyMolecular Diagnostic TechniquesPopulation SurveillancebusinessCoronavirus InfectionsBetacoronavirusRapid CommunicationAlgorithmsRespiratory tractEurosurveillance
researchProduct

Diagnostik und Therapie des Morbus Pompe im Kindesalter

2020

Pompe disease is a rare metabolic myopathy caused by deficiency of lysosomal α-glucosidase. Reduced enzyme activity results in abnormal intra- and extralysosomal glycogen deposition as well as impaired cellular function and autophagy. Age at manifestation and severity of disease depend on residual enzyme activity. Enzyme replacement therapy (ERT) is available since 2006. In infantile onset Pompe disease, the most severe form, markedly prolonged survival has resulted in a new phenotype with symptoms and problems not encountered previously. In addition, it became apparent that antibody formation against the recombinant human enzyme may adversely affect the response to ERT. This review summari…

Pediatricsmedicine.medical_specialtybiologybusiness.industryAutophagy030232 urology & nephrologyMedizinGlycogen deposition610 Medicine & healthDiseaseMetabolic myopathyEnzyme replacement therapymedicine.diseaseEnzyme assay03 medical and health sciences0302 clinical medicine10036 Medical Clinic030225 pediatricsPediatrics Perinatology and Child HealthGlycogen storage disease type IImedicinebiology.proteinbusinessAntibody formation
researchProduct

Differentiation of Penicillium griseofulvum Dierckx isolates by enzyme assays and by patulin and griseofulvin analyses

1990

The production of patulin and griseofulvin by 49 different isolates of Penicillium griseofulvum Dierckx was analyzed by high-performance liquid chromatography. Eleven isolates were obtained from pistachio nuts, 37 were obtained from wheat seeds, and 1 was obtained from the American Type Culture Collection. Activities of 19 enzymes were also assayed by the API ZYM system. From these results it may be deduced that there are two different groups among the strains tested which cannot be distinguished by morphological and cultural characteristics. One group of isolates did not produce detectable amounts of patulin and griseofulvin when grown in sucrose-yeast extract and Wickerham media, while en…

Penicillium griseofulvumHydrolasesApplied Microbiology and BiotechnologyGriseofulvinPatulinLeucyl Aminopeptidasechemistry.chemical_compoundMycotoxinChromatography High Pressure LiquidEcologybiologybeta-GlucosidasePenicilliumPhosphoamidaseFungi imperfectibiology.organism_classificationGriseofulvinEnzyme assayCulture MediaPatulinchemistryBiochemistryPenicilliumbiology.proteinResearch ArticleFood ScienceBiotechnologyApplied and Environmental Microbiology
researchProduct

Kinetics of in vivo inhibition of tissue cathepsin d by pepstatin A

1988

1. 1. We have investigated the kinetics of inhibition of cathepsin D in heart, liver and skeletal muscle of CD-1 mice following administration of 25, 50, 100 and 200 mg/kg i.p. of pepstatin A, a specific inhibitor of this protease. 2. 2. In the liver, a significant inhibition of cathepsin D occurred up to at least 15 days, whereas, in heart and skeletal muscle, this inhibition lasted for a much shorter period of time. 3. 3. These results show that the recovery of enzyme activity to normal values is dose-dependent and that, at the same dose level, marked differences occur in the recovery of enzyme activity in these organ tissues, the liver being the most sensitive one. © 1988.

Pepstatin Amedicine.medical_treatmentPeriod (gene)KineticsCathepsin DBiochemistryCathepsin DMicechemistry.chemical_compoundIn vivoPepstatinsmedicineAnimalsProteasebiologyMusclesMyocardiumSkeletal muscleEnzyme assayKineticsmedicine.anatomical_structureLiverchemistryBiochemistrybiology.proteinFemaleProteinase InhibitorsOligopeptidesPepstatin
researchProduct